Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Esophageal Squamous Cell Carcinoma × Gemcitabine × 30 days × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 17 Carcinoma, Non-Small-Cell Lung 17 Urinary Bladder Neoplasms 15 Lung Neoplasms 13 Ovarian Neoplasms 9 Lymphoma, Large B-Cell, Diffuse 9 Colorectal Neoplasms 9 Non-Muscle Invasive Bladder Neoplasms 7 Neoplasm Metastasis 6 Nasopharyngeal Carcinoma 6 Triple Negative Breast Neoplasms 5 Fallopian Tube Neoplasms 5 Biliary Tract Neoplasms 5 Uterine Cervical Neoplasms 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Neoplasms 4 Gallbladder Neoplasms 4 Cholangiocarcinoma 4 Carcinoma, Transitional Cell 4 Carcinoma, Pancreatic Ductal 4 Breast Neoplasms 4 Rectal Neoplasms 3 Hodgkin Disease 3 Gastrointestinal Neoplasms 3 Colonic Neoplasms 3 Sarcoma 2 Recurrence 2 Osteosarcoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Follicular 2

Interventions

pembrolizumab 7 Cisplatin 6 Paclitaxel 5 Drug Therapy 3 toripalimab 2 Radiotherapy 2 Irinotecan 2 Fluorouracil 2 Carboplatin 2 tislelizumab 1 regorafenib 1 osimertinib 1 nimotuzumab 1 lenvatinib 1 aflibercept 1 Oxaliplatin 1 Nivolumab 1 NEO212 1 Levoleucovorin 1 Leucovorin 1 Ipilimumab 1 IFL protocol 1 Histamine H2 Antagonists 1 Histamine Antagonists 1 Fulvestrant 1 Docetaxel 1 Dexamethasone 1 Chemoradiotherapy 1 Bevacizumab 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡